Daniel Rabczenko

Author PubWeight™ 28.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Heat effects on mortality in 15 European cities. Epidemiology 2008 4.63
2 The temporal pattern of mortality responses to air pollution: a multicity assessment of mortality displacement. Epidemiology 2002 3.21
3 The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect 2003 2.22
4 Pertussis in Poland. Int J Epidemiol 2004 1.64
5 Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study. Cardiol J 2009 1.41
6 Gender-specific mortality associated with alcohol consumption in Poland in transition. Addiction 2005 1.19
7 Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 2004 1.02
8 Association of maternal serum concentrations of 2,2', 4,4'5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (p,p'-DDE) levels with birth weight, gestational age and preterm births in Inuit and European populations. Environ Health 2010 0.97
9 Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland. Biologicals 2004 0.88
10 Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study. Kardiol Pol 2003 0.87
11 [Characteristics of bacteria isolated from body surface of German cockroaches caught in hospitals]. Przegl Epidemiol 2003 0.86
12 Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults. Arch Immunol Ther Exp (Warsz) 2008 0.81
13 Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable? Heart Vessels 2006 0.80
14 [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10]. Pneumonol Alergol Pol 2011 0.80
15 Acute and subacute effects of urban air pollution on cardiopulmonary emergencies and mortality: time series studies in Austrian cities. Int J Environ Res Public Health 2013 0.80
16 Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study. Cardiology 2005 0.79
17 [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)]. Pneumonol Alergol Pol 2008 0.79
18 [Assessment of the determinants of accidents and injuries among elderly people]. Wiad Lek 2002 0.78
19 [Myoglobin and troponin I as markers of myocardial damage during cardioversion of atrial fibrillation]. Pol Arch Med Wewn 2003 0.78
20 Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2005 0.78
21 Detection of Trichinella spiralis DNA in mouse faeces during the early stage of infection. J Microbiol Methods 2009 0.78
22 A1166C polymorphism of the angiotensin AT1 receptor (AT1R) gene alters endothelial response to statin treatment. Clin Chem Lab Med 2007 0.78
23 Factors determining long-term maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. Kardiol Pol 2003 0.77
24 [Survival of cervical cancer patients in selected regions of Poland in 1990-1996, in relation to some prognostic factors]. Przegl Epidemiol 2004 0.77
25 [Microbiological evaluation of risk of legionellosis and practical methods applied for elimination of Legionella pneumophila from hospital water systems]. Przegl Epidemiol 2008 0.76
26 Cell wall carbohydrates content of pathogenic Candida albicans strain morphological forms. Med Dosw Mikrobiol 2013 0.76
27 A decrease of enlarged left atrium following cardioversion of atrial fibrillation predicts the long-term maintenance of sinus rhythm. Kardiol Pol 2005 0.76
28 Differences in breast cancer incidence and stage distribution between urban and rural female population in Podlaskie Voivodship, Poland in years 2001-2002. Ann Agric Environ Med 2010 0.76
29 Breast cancer survival gap between urban and rural female population in Podlaskie Voivodship, Poland, in 2001–2002. Population study. Ann Agric Environ Med 2010 0.75
30 [Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines]. Med Dosw Mikrobiol 2014 0.75
31 [Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part I. Potency of DTP vaccine]. Przegl Epidemiol 2004 0.75
32 [Synantropic cockroaches (Blattella germanica L.) in hospital environment--microbiological hazard for patients and hospital infections risk assessment]. Przegl Epidemiol 2006 0.75
33 [Rescue procedures in the major trauma of upper extremities - the role of the Polish medical air rescue in the therapeutic process]. Med Pr 2014 0.75
34 Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model. Vaccine 2011 0.75
35 [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations]. Med Dosw Mikrobiol 2007 0.75
36 Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland. Arch Immunol Ther Exp (Warsz) 2014 0.75
37 [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation]. Pol Arch Med Wewn 2002 0.75
38 [Time series analysis for the evaluation of risk of death associated with environmental air pollution]. Rocz Panstw Zakl Hig 2003 0.75
39 [Immunological response (IgM) to Legionella pneumophila infection in children]. Przegl Epidemiol 2007 0.75
40 [Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part II. Consistency of control and production]. Przegl Epidemiol 2004 0.75
41 Cardiovascular therapy, diagnostic procedures, and control of risk factors in patients with diabetes or coronary artery disease in Poland: the Kardia‑Pol registry. Pol Arch Med Wewn 2012 0.75
42 Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation. Kardiol Pol 2005 0.75
43 Effectiveness of experimental whole-cell pertussis vaccines in murine model. Med Dosw Mikrobiol 2014 0.75
44 [The studies of elimination of nontypeable Haemophilus influenzae strains using the animal model of infection]. Med Dosw Mikrobiol 2013 0.75
45 Characterization and Optimization of Biosynthesis of Bioactive Secondary Metabolites Produced by Streptomyces sp. 8812. Pol J Microbiol 2016 0.75
46 [Influence of sinus rhythm restoration and maintenance on left ventricle diameter and function in patients with persistent atrial fibrillation--one year follow-up]. Pol Arch Med Wewn 2005 0.75
47 Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation. Kardiol Pol 2005 0.75
48 [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice]. Med Dosw Mikrobiol 2007 0.75
49 [Evaluation of effectiveness of several repellents against mosquito bites available at the Polish market]. Przegl Epidemiol 2012 0.75
50 [Value of electrocardiographic treadmill test for rate control strategy in permanent atrial fibrillation]. Pol Arch Med Wewn 2005 0.75
51 ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES. Acta Pol Pharm 2015 0.75